Eli Lilly can now seek regulatory approval and potentially launch the next-generation drug in 2027.
Next-gen obesity drug helps patients lose 28% of body weight: Eli Lilly
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!